Baird Capital brings global approach to small healthcare market

Michael Bernstein, Robert W. Baird & Co, private equity, healthcare, autism, substance abuse
Michael Bernstein, partner at Robert W. Baird & Co. Photo courtesy of the firm.
  • Eyes providers of treatment for autism, TBI, substance abuse
  • Baird invests from first global fund, closed this summer
  • Healthcare team looks for sub-$5 mln-EBITDA opportunities
A global fund with a sweet spot in the lower middle market is a unique model that should bode well for Baird Capital as it pursues platforms in healthcare verticals like behavioral health, an executive of the firm said. Michael ...

This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period

If you already have an active Buyouts subscription, please sign in to view this article.

Digital Edition

To read a digital copy of our latest magazine

click here

PE News Briefs